cell grafts

Novartis backs Gamida Cell’s $40M raise to fund a looming PhIII study, marketing and manufacturing prep
Endpoints
Tue, 06/20/17 - 09:20 am
Novartis
Gamida Cell
clinical trials
cell grafts
bone marrow
leukemia
lymphoma